# Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-comparative-effectiveness-of-triplets-containing-bortezomib-b/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Faith E. Davies,Robert M. Rifkin,Caitlin Costello,Gareth J. Morgan,Saad Z. Usmani,Rafat Abonour,Antonio Palumbo,Dorothy Romanus,Roman Hájek,Evangelos Terpos,Dasha Cherepanov,Dawn Marie Stull,Hui Huang,Xavier Leleu,Jesús G. Berdeja,Hans C. Lee,Katja Weisel,Michael A. Thompson,Mario Boccadoro,Jeffrey A. Zonder,Gordon Cook,Noemí Puig,Jorge Vela‐Ojeda,Eileen Farrelly,Aditya Raju,Marlo Blazer,Ajai Chari |
| Citations | 33 |
| DOI | 10.1007/s00277-021-04534-8 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s00277-021-04534-8.pdf |
| OpenAlex ID | https://openalex.org/W3162052183 |
| PMID | 33970288 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Eileen Farrelly](https://scholariq.org/researchers/eileen-farrelly/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.